Associate Director/Director Drug Product, CMC

remote director seen live 15h ago

About Us We are developing potentially best in class therapies for patients living with severe autoimmune diseases. Our lead antibody, claseprubart (DNTH103), is purposefully engineered with extended half-life, improved potency, and high selectivity for only the active C1s

Apply on Dianthus Therapeutics's site

This link goes straight to the employer's greenhouse page. Posted 90 days ago.We last confirmed it was open 15h ago.